Riskpilot← Back to searchSign inGet full accessMedicall-Nordic AB
ABDissolvedOrg 5562961911Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19870 employees
Revenue 2019
SEK 0
EBITDA margin
—
+110% vs 2018
Equity ratio
41.9%
Financial strength
Net profit 2019
SEK 7K
+105% vs 2018
| Revenue | SEK 0 | — |
| EBITDA | SEK 13K | +110% |
| Net profit | SEK 7K | +105% |
| Total assets | SEK 503K | -62% |
| Equity | SEK 211K | -21% |
| Employees | 0 | — |
Legal name
Medicall-Nordic AB
Org number
5562961911
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
21 maj 1987
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Company purpose
Äga och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Revenue | 11 148 | 8 883 | 2 140 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | 2 356 | 1 561 | −129 | 13 |
| Depreciation & amort. | −13 | −15 | −0 | −0 |
| EBIT | 2 343 | 1 546 | −129 | 13 |
| Net financials | 546 | 57 | −1 | −6 |
| Profit before tax | 3 781 | 1 602 | −130 | 7 |
| Tax | −432 | −363 | −0 | −0 |
| Net profit | 3 349 | 1 239 | −130 | 7 |
| Item | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Total assets | 6 772 | 3 645 | 1 327 | 503 |
| Equity | 3 509 | 2 248 | 268 | 211 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 3 263 | 1 397 | 1 059 | 291 |
| Total debt | 3 263 | 1 397 | 1 059 | 291 |
EBITDA margin
1300000.0%
This company
15.8%
Market median
+8227748% vs market
20162019
Equity ratio
41.9%
This company
38.2%
Market median
+10% vs market
20162019
Return on equity
3.3%
This company
18.4%
Market median
-82% vs market
20162019
Net profit margin
700000.0%
This company
8.1%
Market median
+8641875% vs market
20162019
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162019
Debt / equity
1.38×
This company
0.62×
Market median
-123% vs market
20162019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PA | Audit | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Deputy Board Member | 2020 – 2020 | |
| Chairman | 2020 – 2020 | |
| Board of Directors | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medicall-Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Anders Erik Lindby | Audit | 0 companies |
| Hanna Erica Andres Sandberg | Deputy Board Member | 0 companies |
| Hans-Olof Sandberg | Chairman | 0 companies |
| Inga Helena Sandberg | Board of Directors | 0 companies |